Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 2—February 2021
CME ACTIVITY - Synopsis

Plasmodium ovale wallikeri and P. ovale curtisi Infections and Diagnostic Approaches to Imported Malaria, France, 2013–2018

Valentin JosteComments to Author , Justine Bailly, Véronique Hubert, Cécile Pauc, Mathieu Gendrot, Emilie Guillochon, Marylin Madamet, Marc Thellier, Eric Kendjo, Nicolas Argy, Bruno Pradines, Sandrine Houzé, and on behalf of the French National Reference Center for Imported Malaria Study Group1
Author affiliations: Centre National de Référence du Paludisme, Paris, France (V. Joste, J. Bailly, V. Hubert, C. Pauc, N. Argy, S. Houzé); Université de Paris, Paris (N. Argy, S. Houzé); Laboratoire de Parasitologie-Mycologie, Paris (V. Joste, N. Argy, S. Houzé); Institut de Recherche Biomédicale des Armées, Marseille, France (M. Gendrot, M. Madamet, B. Pradines); Aix–Marseille Université, Marseille (M. Gendrot, M. Madamet, B. Pradines); Instituts Hospitalo–Universitaires Méditerranée Infection, Marseille (M. Gendrot, M. Madamet, B. Pradines); Centre National de Référence du Paludisme, Marseille (M. Madamet, B. Pradines); Sorbonne Université, Paris, France (M. Thellier, E. Kendjo)

Main Article

Table 1

Demographic and epidemiologic characteristics of patients infected with Plasmodium ovale wallikeri and P. ovale curtisi, France, January 2013–December 2018*

Characteristic P. ovale curtisi, n = 309 P. ovale wallikeri, n = 368 p value
Age, y, median (IQR)
 31 (21–47)
 34 (21–47)
 0.973
Sex, % 0.716
M 63.4 61.4
F
 36.6
 38.6
Ethnicity 0.502
Black 200 (74.3) 239 (75.7)
White 64 (23.8) 68 (21.5)
Asian 2 (0.7) 1 (0.3)
Other
 3 (1.2)
 8 (2.5)
If African, place of birth 0.420
Africa 144 (83.2) 164 (80)
Nonendemic country
 29 (16.8)
 41 (20)
Type of patient 0.192
Immigrant† 23 (11.6) 21 (8.6)
Traveler‡ 137 (68.8) 187 (77.3)
Visiting friends or relatives 109 (79.6) 152 (81.3)
Tourism 6 (4.4) 8 (4.3)
Work 22 (16) 27 (14.4)
Resident 19 (9.5) 20 (8.3)
Expatriate 6 (38.6) 10 (50)
Humanitarian 13 (61.4) 10 (50)
Military
 20 (10.1)
 14 (5.8)
Duration of travel, d, median (IQR)
 58 (29–91)
 50 (24–91)
 0.106
Chemoprophylaxis 0.882
Yes 97 (40) 123 (39.3)
Complete 35 (44.9) 42 (43.8)
Incomplete 43 (55.1) 54 (56.2)
Prematurely stopped 26 (60.5) 36 (66.7)
Occasionally taking 17 (39.5) 18 (33.3)
No data 19 (NA) 27 (NA)
No
 146 (60)
 190 (60.7)
Using bed nets 0.119
Yes 48 (26.7) 41 (20.2)
No 130 (73.3) 162 (79.8)

*Values are no. (%) patients except as indicated. IQR, interquartile range; NA, not available.
†A person who was born and lived in Africa.
‡A person who lived in a non–Plasmodium-endemic country.

Main Article

1Additional members of the French National Reference Center for Imported Malaria Study Group who contributed data are listed at the end of this article.

Page created: January 04, 2021
Page updated: January 21, 2021
Page reviewed: January 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external